The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy

The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy

Urinary symptoms occur in 19% of human T-cell lymphotropic virus type 1 (HTLV-1)-infected patients who do not fulfill criteria for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and in almost 100% of HAM/TSP patients. Few studies have evaluated therapies for overactive bladder (...

Full description

Bibliographic Details
Main Authors: José Abraão Carneiro Neto, Valéria Gusmão Bittencourt, Cassius de Oliveira, Rosana Andrade, Edgar Marcelino de Carvalho
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2014-07-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
HTLV-1
Overactive bladder
Botox
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822014000400528&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822014000400528&lng=en&tlng=en

Similar Items